治疗前后18F-FDG PET-CT体积参数变化对胸膜间皮瘤总生存率的影响

IF 0.3 Q4 ONCOLOGY
Faris Tüzün, S. Ebinç, M. Kaplan, İ. Kaplan, H. Kömek, Z. Oruç, Şadiye Kemal Tuzcu, B. Taşdemir
{"title":"治疗前后18F-FDG PET-CT体积参数变化对胸膜间皮瘤总生存率的影响","authors":"Faris Tüzün, S. Ebinç, M. Kaplan, İ. Kaplan, H. Kömek, Z. Oruç, Şadiye Kemal Tuzcu, B. Taşdemir","doi":"10.5603/ocp.2023.0022","DOIUrl":null,"url":null,"abstract":"Introduction. This study aimed to examine the efficacy of positron emission tomography in fusion with computed tomography (PET-CT) parameters in predicting survival outcomes for patients with malignant pleural mesothelioma. Material and methods. This study retrospectively evaluated the data of 250 patients who were followed up after a diagnosis of malignant pleural mesothelioma. The relationship of pre-treatment [maximum standardized uptake value (SUV max1 ), metabolic tumor volume (MTV1), total lesion glycolysis (TLG1), tumor/background (TBR1), pleural thickness1), post-treatment (SUV max2 , MTV2, TLG2, TBR2, pleural thickness2], and D PET-CT parameters with survival was retrospectively evaluated in 36 patients whose pre-and post-treatment CT scan examinations were complete. Results. The median age of the patients was 57.5 years, ranging from 35 to 76. Median follow-up time was 16 months, with a range of 7 to 42 months. Median survival was calculated as 18.8 months for all patients. Based on the determined cut-off values, overall survival was determined as 29.9 months in patients with TLG2 ≤ 158 compared to 16 months in patients with TLG2 > 158 (p = 0.009) and as 30.9 months in patients with D TLG ≤ –62.58 compared to 16 months in patients with D TLG > –62.58 (p = 0.001). In addition, median overall survival (OS) was determined as 29.9 months in patients with MTV2 ≤ 63.9 compared to 16 months in patients with MTV2 > 63.9 (p = 0.007) and as 29.9 months in patients with D MTV ≤ –54.03 compared to 16 months in patients with D MTV > –54.03 (p = 0.002). When evaluated with respect to TBR2; median OS was 29.9 months in patients with TBR2 ≤ 1.84 compared to 16 months in patients with TBR2 > 1.84 (p = 0.039). Conclusions. Our research findings indicate a correlation between OS and volumetric PET-CT measures, specifically TLG and MTV.","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"3 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of the changes between preand post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma\",\"authors\":\"Faris Tüzün, S. Ebinç, M. Kaplan, İ. Kaplan, H. Kömek, Z. Oruç, Şadiye Kemal Tuzcu, B. Taşdemir\",\"doi\":\"10.5603/ocp.2023.0022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. This study aimed to examine the efficacy of positron emission tomography in fusion with computed tomography (PET-CT) parameters in predicting survival outcomes for patients with malignant pleural mesothelioma. Material and methods. This study retrospectively evaluated the data of 250 patients who were followed up after a diagnosis of malignant pleural mesothelioma. The relationship of pre-treatment [maximum standardized uptake value (SUV max1 ), metabolic tumor volume (MTV1), total lesion glycolysis (TLG1), tumor/background (TBR1), pleural thickness1), post-treatment (SUV max2 , MTV2, TLG2, TBR2, pleural thickness2], and D PET-CT parameters with survival was retrospectively evaluated in 36 patients whose pre-and post-treatment CT scan examinations were complete. Results. The median age of the patients was 57.5 years, ranging from 35 to 76. Median follow-up time was 16 months, with a range of 7 to 42 months. Median survival was calculated as 18.8 months for all patients. Based on the determined cut-off values, overall survival was determined as 29.9 months in patients with TLG2 ≤ 158 compared to 16 months in patients with TLG2 > 158 (p = 0.009) and as 30.9 months in patients with D TLG ≤ –62.58 compared to 16 months in patients with D TLG > –62.58 (p = 0.001). In addition, median overall survival (OS) was determined as 29.9 months in patients with MTV2 ≤ 63.9 compared to 16 months in patients with MTV2 > 63.9 (p = 0.007) and as 29.9 months in patients with D MTV ≤ –54.03 compared to 16 months in patients with D MTV > –54.03 (p = 0.002). When evaluated with respect to TBR2; median OS was 29.9 months in patients with TBR2 ≤ 1.84 compared to 16 months in patients with TBR2 > 1.84 (p = 0.039). Conclusions. Our research findings indicate a correlation between OS and volumetric PET-CT measures, specifically TLG and MTV.\",\"PeriodicalId\":42942,\"journal\":{\"name\":\"Oncology in Clinical Practice\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology in Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/ocp.2023.0022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ocp.2023.0022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

介绍。本研究旨在探讨正电子发射断层扫描与计算机断层扫描(PET-CT)参数融合预测恶性胸膜间皮瘤患者生存结果的有效性。材料和方法。本研究回顾性评估了250例诊断为恶性胸膜间皮瘤后随访的患者资料。回顾性评价36例完成治疗前后CT扫描检查的患者治疗前[最大标准化摄取值(SUV max1)、肿瘤代谢体积(MTV1)、病灶总糖解(TLG1)、肿瘤/背景(TBR1)、胸膜厚度1)、治疗后(SUV max2、MTV2、TLG2、TBR2、胸膜厚度2]、D PET-CT参数与生存率的关系。结果。患者的中位年龄为57.5岁,年龄范围为35 - 76岁。中位随访时间为16个月,7 ~ 42个月。所有患者的中位生存期为18.8个月。根据确定的临界值,TLG2≤158的患者总生存期为29.9个月,而TLG2 > 158的患者总生存期为16个月(p = 0.009); D TLG≤-62.58的患者总生存期为30.9个月,而D TLG > -62.58的患者总生存期为16个月(p = 0.001)。此外,MTV2≤63.9的患者的中位总生存期(OS)为29.9个月,MTV2 > 63.9的患者为16个月(p = 0.007); D MTV≤-54.03的患者为29.9个月,D MTV > -54.03的患者为16个月(p = 0.002)。当对TBR2进行评估时;TBR2≤1.84的患者中位OS为29.9个月,而TBR2 > 1.84的患者中位OS为16个月(p = 0.039)。结论。我们的研究结果表明,OS和体积PET-CT测量之间存在相关性,特别是TLG和MTV。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of the changes between preand post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma
Introduction. This study aimed to examine the efficacy of positron emission tomography in fusion with computed tomography (PET-CT) parameters in predicting survival outcomes for patients with malignant pleural mesothelioma. Material and methods. This study retrospectively evaluated the data of 250 patients who were followed up after a diagnosis of malignant pleural mesothelioma. The relationship of pre-treatment [maximum standardized uptake value (SUV max1 ), metabolic tumor volume (MTV1), total lesion glycolysis (TLG1), tumor/background (TBR1), pleural thickness1), post-treatment (SUV max2 , MTV2, TLG2, TBR2, pleural thickness2], and D PET-CT parameters with survival was retrospectively evaluated in 36 patients whose pre-and post-treatment CT scan examinations were complete. Results. The median age of the patients was 57.5 years, ranging from 35 to 76. Median follow-up time was 16 months, with a range of 7 to 42 months. Median survival was calculated as 18.8 months for all patients. Based on the determined cut-off values, overall survival was determined as 29.9 months in patients with TLG2 ≤ 158 compared to 16 months in patients with TLG2 > 158 (p = 0.009) and as 30.9 months in patients with D TLG ≤ –62.58 compared to 16 months in patients with D TLG > –62.58 (p = 0.001). In addition, median overall survival (OS) was determined as 29.9 months in patients with MTV2 ≤ 63.9 compared to 16 months in patients with MTV2 > 63.9 (p = 0.007) and as 29.9 months in patients with D MTV ≤ –54.03 compared to 16 months in patients with D MTV > –54.03 (p = 0.002). When evaluated with respect to TBR2; median OS was 29.9 months in patients with TBR2 ≤ 1.84 compared to 16 months in patients with TBR2 > 1.84 (p = 0.039). Conclusions. Our research findings indicate a correlation between OS and volumetric PET-CT measures, specifically TLG and MTV.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.90
自引率
20.00%
发文量
46
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信